Insider Transactions in Q3 2022 at Immunovant, Inc. (IMVT)
Insider Transaction List (Q3 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 30
2022
|
Atul Pande Director |
BUY
Open market or private purchase
|
Indirect |
15,000
+42.86%
|
$75,000
$5.6 P/Share
|
|
Sep 29
2022
|
Frank Torti Director |
BUY
Open market or private purchase
|
Direct |
20,000
+4.84%
|
$100,000
$5.81 P/Share
|
|
Sep 28
2022
|
Peter Salzmann Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
1,605
-0.16%
|
$6,420
$4.67 P/Share
|
|
Sep 28
2022
|
Julia G. Butchko Chief Development Officer |
SELL
Open market or private sale
|
Direct |
535
-0.14%
|
$2,140
$4.67 P/Share
|
|
Aug 30
2022
|
Peter Salzmann Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
1,644
-0.16%
|
$8,220
$5.83 P/Share
|
|
Aug 30
2022
|
Julia G. Butchko Chief Development Officer |
SELL
Open market or private sale
|
Direct |
548
-0.14%
|
$2,740
$5.83 P/Share
|
|
Aug 17
2022
|
Frank Torti Director |
BUY
Grant, award, or other acquisition
|
Direct |
225,632
+37.67%
|
-
|
|
Aug 17
2022
|
Douglas J. Hughes Director |
BUY
Grant, award, or other acquisition
|
Direct |
21,059
+17.22%
|
-
|
|
Aug 17
2022
|
George V Migausky Director |
BUY
Grant, award, or other acquisition
|
Direct |
21,059
+16.07%
|
-
|
|
Aug 17
2022
|
Atul Pande Director |
BUY
Grant, award, or other acquisition
|
Direct |
21,059
+20.24%
|
-
|
|
Aug 17
2022
|
Andrew J. Fromkin Director |
BUY
Grant, award, or other acquisition
|
Direct |
21,059
+19.22%
|
-
|
|
Aug 17
2022
|
Peter Salzmann Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
451,264
+31.01%
|
-
|
|
Aug 17
2022
|
Eva Renee Barnett Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
112,816
+28.33%
|
-
|
|
Aug 17
2022
|
Julia G. Butchko Chief Development Officer |
BUY
Grant, award, or other acquisition
|
Direct |
112,816
+22.26%
|
-
|
|
Aug 17
2022
|
William L. Macias Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
112,816
+26.78%
|
-
|
|
Aug 17
2022
|
Mark S. Levine Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
112,816
+30.6%
|
-
|
|
Jul 27
2022
|
Peter Salzmann Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
1,528
-0.28%
|
$6,112
$4.27 P/Share
|
|
Jul 27
2022
|
Julia G. Butchko Chief Development Officer |
SELL
Open market or private sale
|
Direct |
510
-0.18%
|
$2,040
$4.27 P/Share
|
|
Jul 22
2022
|
William L. Macias Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
322
-0.16%
|
$1,288
$4.7 P/Share
|